Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
anti-COX1, mAb
As low as
715
CHF
CHF 715.00
In stock
Only %1 left
BRT-A03583-C200200 µgCHF 715.00

Product Details | |
---|---|
Synonyms | Cyclooxygenase-1; Prostaglandin Endoperoxide Synthase 1; Prostaglandin G/H Synthase 1; Prostaglandin H2 Synthase 1; PGHS-1 |
Product Type | Monoclonal Antibody |
Properties | |
Source/Host | Mouse |
Immunogen/Antigen | Purified ovine COX. |
Application | EIA |
Formulation | Liquid. In Phosphate Buffer. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Bertin Bioreagent |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
Cyclooxygenase 1 (COX-1) is a bifunctional enzyme that exhibits both COX and peroxidase activities. COX-1 is constitutively expressed in the gastrointestinal tract, kidney, spleen, liver, and lung and localizes to the endoplasmic reticulum. The COX component converts arachidonic acid to a hydroperoxyl endoperoxide prostaglandin G2 (PGG2) and the peroxidase component reduces the endoperoxide to the corresponding alcohol PGH2, the precursor of PGs, thromboxanes, and prostacyclins. COX-1 is the target of many non-steroidal anti-inflammatory drugs (NSAIDs) and is responsible for the undesirable gastrointestinal and renal side effects, such as ulcer formation and reductions in the glomerular filtration rate, respectively.